Please login to the form below

Not currently logged in
Email:
Password:

real-world evidence

This page shows the latest real-world evidence news and features for those working in and with pharma, biotech and healthcare.

Beneluxa: the future of European market access?

Beneluxa: the future of European market access?

As the collection of real-world evidence (RWE) is part of the Spinraza agreement, I ask whether or not this will become standard in the future – and hand in hand with ... One prerequisite for a shift towards an outcomes-based reimbursement model is of

Latest news

  • UK’s genomics leadership attracts IQVIA investment, regardless of Brexit UK’s genomics leadership attracts IQVIA investment, regardless of Brexit

    owned Genomics England is to launch a collaboration to integrate its world-leading genomic database with IQVIA’s UK clinical trials capabilities, a key milestone in its development. ... and delivery of hundreds of additional clinical trials and

  • Abbott’s wearable glucose monitor to be available across England Abbott’s wearable glucose monitor to be available across England

    Years of clinical and real world evidence show that when people use this technology, they have both short and long term benefits to their diabetes control.  When Abbott set out to ... This will be based on previous national guidance issued- with the

  • Entering the era of digital trials Entering the era of digital trials

    In the first steps in the process, sponsors are factoring real-world evidence into trial designs and using models to forecast outcomes. ... This is important given evidence that vital sign data collected in clinics and in the real world differs.

  • The Final Frontier The Final Frontier

    Often, people say that there’s no evidence for the use of medical cannabis. ... But we do have real-world evidence. We have millions of patient-years of data in various countries.

  • Medical cannabis now available on prescription, for some Medical cannabis now available on prescription, for some

    The UK's rescheduling of cannabis-based medicine has come about from a groundswell of patient need, but is rooted in scientific evidence and experience,” comments Professor Marie Fallon of The ... There is a significant real-world experience and

More from news
Approximately 10 fully matching, plus 66 partially matching documents found.

Latest Intelligence

  • Launch excellence: beyond the six-month mantra Launch excellence: beyond the six-month mantra

    Individualised medicine, real-world evidence and algorithmic prescribing are emerging challenges and opportunities that launch teams need to address – how each company responds to these depends on its own unique context,

  • Escaping the spin cycle of sub-optimal launch Escaping the spin cycle of sub-optimal launch

    Growing demand for real-world evidence and the drive towards individualised medicines are bringing new considerations to launch planning,” says Ed. ... In today’s world, new therapies are launching into much more complex markets than they did in the

  • Relearning launch: Four key dynamics for pharma launches in 2019 Relearning launch: Four key dynamics for pharma launches in 2019

    Changes in approach in the US, EU and China are driving more parallel studies, more accelerated approvals and the accumulation of more real-world evidence for additional indications. ... Some of that evidence will be advanced at a national or global level

  • Leave or remain? Winning the employee referendum Leave or remain? Winning the employee referendum

    Overall turnover is misleading. The real measure of success is to track ‘regretted’ turnover: high potential or high performers. ... aren’t swayed by promises on the sides of buses, but by the real-world evidence of their experiences in the

  • Stakeholder dialogue in Europe’s adaptive pathways pilot Stakeholder dialogue in Europe’s adaptive pathways pilot

    Evidence suggests that medicines using the resulting accelerated access initiatives experience variable reimbursement outcomes due to uncertainties in the clinical or economic evidence base. ... The use of real-world evidence (RWE) as a complement to

More from intelligence
Approximately 8 fully matching, plus 45 partially matching documents found.

Latest appointments

  • Remi Gauchoux joins Carenity Remi Gauchoux joins Carenity

    Gauchoux has a 20-year international experience in healthcare and the CRO industries with expertise in late phase and real-world evidence analysis.

  • Dr Ameet Nathwani moves from Novartis to Sanofi Dr Ameet Nathwani moves from Novartis to Sanofi

    Oliver Brandicourt, Sanofi's chief executive officer, said: “Our industry is experiencing increased pressure to support reimbursement with customized data from real-world evidence, demonstrate ongoing benefit-risk of registered products

  • EMA's Dr Stella Blackburn joins Quintiles EMA's Dr Stella Blackburn joins Quintiles

    Cynthia Verst, president, real world and late phase research at Quintiles, said: “Stella's experience developing innovative risk management solutions is a tremendous addition to our team. ... She said: “Together with my colleagues at Quintiles, I aim

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

DNA
Why precision medicine demands precision engagement
The speed of innovation brings its own challenges, says cloud computing expert...
Unlocking the potential of science and technology in the UK
Greater collaboration is vital in post-Brexit UK, says Alderley Park leader...
NHS regional footprints
What to expect from 2019...

Infographics